GO:0015886 heme transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015886 (heme transport) describes the directed movement of heme, an iron-porphyrin complex, into, out of, or within cells by transporters or pores.
• Heme transport is essential for erythropoiesis, iron availability, and cellular energy metabolism, linking heme synthesis to systemic iron homeostasis.
• Key transporters include SLCO2B1, which enhances cellular iron availability, and mitochondrial transport machinery that moves heme across organellar membranes.
• Defects in heme transport are implicated in anemias, porphyrias, and disorders of iron overload, making it a target for therapeutic research.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate heme transport genes.
• Understanding heme transport requires integrating biochemical, genetic, and imaging methods to track heme movement and its metabolic consequences.
Description
Heme transport (GO:0015886) is the biological process that mediates the directed movement of heme, an iron complexed in a porphyrin ring, into, out of, or within a cell, or between cells, via transporters or pores. This process is fundamental because heme serves as a prosthetic group for proteins involved in oxygen transport, electron transfer, and oxidative metabolism, and its trafficking must be tightly coordinated with heme biosynthesis and iron metabolism. Researchers study heme transport to understand how cells acquire and distribute this essential cofactor, and how disruptions contribute to disease. The identification of specific transporters such as SLCO2B1 has provided molecular entry points for investigating heme uptake and its impact on cellular iron availability. Moreover, mitochondrial heme transport mechanisms are critical for heme synthesis and export, linking organellar function to systemic iron homeostasis. Given its broad physiological importance, heme transport is a vibrant area of research with implications for hematology, hepatology, and metabolic disorders.
heme transport At A Glance
| GO ID | GO:0015886 |
|---|---|
| GO term | heme transport |
| Ontology | biological_process |
| Synonym | haem transport |
| Major function | Directed movement of heme across cellular membranes via transporters or pores |
| Related processes | Heme biosynthesis, iron metabolism, erythropoiesis, mitochondrial transport |
| Key transporters | SLCO2B1, mitochondrial heme transport machinery |
| Disease relevance | Anemias, porphyrias, iron overload disorders |
What Is GO:0015886?
In our own words, GO:0015886 heme transport refers to the directed movement of heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring, into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. This definition encompasses the molecular machinery that facilitates heme translocation across membranes, ensuring its availability for incorporation into hemoproteins and its safe trafficking to avoid toxicity.
Why Is heme transport Important in Cell Biology?
Heme transport is critically important because heme is indispensable for oxygen transport, mitochondrial respiration, and numerous metabolic reactions, and its movement must be precisely regulated to prevent toxicity and ensure proper iron utilization. Dysregulation of heme transport is linked to hematological disorders, liver diseases, and metabolic dysfunction, making it a key area for understanding disease mechanisms and developing targeted therapies.
• Essential for erythropoiesis and hemoglobin synthesis in red blood cells.
• Links heme biosynthesis to systemic iron metabolism and cellular energy status.
• Facilitates heme uptake and distribution to hemoproteins in various tissues.
• SLCO2B1-mediated heme transport enhances cellular iron availability, impacting iron homeostasis.
• Mitochondrial heme transport is required for heme synthesis and export.
• Defects in heme transport contribute to anemias and porphyrias.
• Heme transport influences redox balance and gene regulation through the hemopexin system.
• Provides targets for therapeutic intervention in iron-related disorders.
• Critical for understanding host-pathogen interactions involving heme acquisition.
• Enables metabolic-scale screens to identify novel transporters and regulators.
What Happens During heme transport?
Heme Uptake Across the Plasma Membrane
In simple terms: Cells take in heme from their surroundings using specialized transporter proteins.
Heme transport begins with the uptake of heme across the plasma membrane, often mediated by specific transporters. SLCO2B1 has been identified as a heme transporter that enhances cellular iron availability, demonstrating a direct role in heme uptake. This process is essential for cells that cannot synthesize sufficient heme and rely on exogenous sources, such as erythroid precursors. The mechanism involves recognition and translocation of heme, potentially coupled to proton or ion gradients, as suggested for other solute carriers.
Intracellular Heme Trafficking
In simple terms: Once inside, heme is moved to different compartments where it is needed.
After uptake, heme must be trafficked within the cell to various organelles, including mitochondria, endoplasmic reticulum, and nucleus, to be incorporated into hemoproteins or degraded. This intracellular movement is facilitated by heme-binding proteins and possibly by membrane contact sites. The process ensures that heme is delivered to targets such as cytochromes and globins while preventing free heme toxicity.
Mitochondrial Heme Transport
In simple terms: Heme moves in and out of mitochondria, the cell's powerhouses, through dedicated machinery.
Mitochondria are central to heme biosynthesis and also require heme for respiratory chain complexes. Heme transport across mitochondrial membranes involves specific export and import mechanisms, as reviewed by Ali et al.. The inner membrane transporter ABCB10 and other proteins have been implicated in heme export from mitochondria, linking heme synthesis to cellular demands. This transport is critical for erythropoiesis, where large amounts of heme are needed for hemoglobin.
Heme Efflux and Systemic Distribution
In simple terms: Cells can release heme, which is then carried through the body by proteins like hemopexin.
Heme efflux from cells, particularly from hepatocytes and macrophages, contributes to systemic heme distribution. The hemopexin heme transport system binds free heme in plasma and delivers it to cells expressing hemopexin receptors, playing a role in iron recycling and redox regulation. This pathway is important for recovering iron from senescent red blood cells and for protecting against heme-mediated oxidative damage.
Regulation of Heme Transport
In simple terms: The movement of heme is controlled by the cell's needs and iron levels.
Heme transport is regulated at multiple levels, including transcriptional control of transporter genes and post-translational modifications. For example, SLCO2B1 expression can be induced under conditions of iron deficiency, enhancing heme uptake to improve iron availability. Additionally, the interplay between heme biosynthesis and transport is coordinated with iron metabolism to maintain cellular homeostasis. Dysregulation of these regulatory circuits can lead to disease.
Key Genes Involved in GO:0015886 heme transport
The following genes and proteins are key players in heme transport, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLCO2B1 | Heme transporter that enhances cellular iron availability | Identified in metabolic-scale screens; target for iron metabolism studies |
| ABCB10 | Mitochondrial heme export | Involved in heme synthesis and erythropoiesis |
| FLVCR1 | Heme export from cells | Mutations cause anemia and sensory neuropathy |
| HRG1 (SLC48A1) | Heme import into macrophages | Essential for iron recycling |
| HEPH | Hephaestin, facilitates heme export | Links heme transport to iron homeostasis |
| HPX | Hemopexin, binds free heme in plasma | Delivers heme to cells via receptor-mediated endocytosis |
| CD91 (LRP1) | Hemopexin receptor | Mediates heme uptake from hemopexin complexes |
| ABCG2 | Heme efflux transporter | Affects heme and porphyrin transport |
| SLC46A1 | Heme carrier protein 1 (HCP1) | Intestinal heme absorption |
| FECH | Ferrochelatase, inserts iron into protoporphyrin | Final step of heme biosynthesis, linked to transport |
| ALAS1 | Delta-aminolevulinate synthase 1 | Regulates heme biosynthesis in non-erythroid cells |
| ALAS2 | Delta-aminolevulinate synthase 2 | Erythroid-specific heme biosynthesis |
| GATA1 | Transcription factor for erythroid genes | Regulates heme transport and biosynthesis genes |
| HIF1A | Hypoxia-inducible factor 1-alpha | Regulates iron and heme transport under hypoxia |
| IRP1/IRP2 | Iron regulatory proteins | Post-transcriptional regulation of heme transport genes |
| NCOA4 | Ferritinophagy receptor | Links iron availability to heme synthesis |
| SLC25A37 | Mitochondrial iron importer (MFRN1) | Provides iron for heme synthesis |
How Is heme transport Regulated?
Heme transport is regulated by a complex network that integrates iron availability, oxygen levels, and erythroid differentiation. The transcription factor GATA1 controls the expression of multiple genes involved in heme biosynthesis and transport during erythropoiesis. Hypoxia-inducible factor 1-alpha (HIF1A) upregulates genes that increase iron uptake and heme transport under low oxygen conditions. Iron regulatory proteins (IRP1/IRP2) modulate the stability and translation of mRNAs encoding heme transport proteins in response to cellular iron levels. Additionally, SLCO2B1 expression is induced by iron deficiency, enhancing heme uptake to improve iron availability. These regulatory mechanisms ensure that heme transport matches cellular demands and prevents toxicity.
heme transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FLVCR1 | Anemia, sensory neuropathy | Knockout mouse, patient-derived iPSCs |
| ABCB10 | Erythropoietic protoporphyria-like, anemia | Conditional knockout in erythroid cells |
| SLCO2B1 | Iron overload, cancer metabolism | Overexpression and knockout cell lines |
| HPX | Hemopexin deficiency, hemolysis | Hpx knockout mouse |
| FECH | Erythropoietic protoporphyria | Point mutation knock-in mouse |
Heme Transport Defects in Anemias
Disruptions in heme transport can lead to anemias due to impaired heme availability for hemoglobin synthesis. Mutations in FLVCR1, a heme exporter, cause severe anemia and sensory neuropathy, highlighting the importance of heme efflux in erythroid cells. Similarly, defects in mitochondrial heme export via ABCB10 affect erythropoiesis and red blood cell production. Understanding these transport pathways offers insights into the pathophysiology of anemias and potential therapeutic targets.
Porphyrias and Heme Transport
Porphyrias are disorders of heme biosynthesis, but heme transport also plays a role in their clinical manifestations. Accumulation of porphyrin intermediates can be toxic, and efficient heme transport may mitigate damage by facilitating heme export or uptake. For example, ABCG2 transports porphyrins and heme, and its dysfunction may contribute to porphyria phenotypes. Research into heme transport in porphyrias aims to restore heme homeostasis and reduce toxic intermediate buildup.
Iron Overload and Metabolic Disorders
Heme transport influences systemic iron balance. SLCO2B1-mediated heme uptake enhances cellular iron availability, and its dysregulation could contribute to iron overload or deficiency. In conditions like hereditary hemochromatosis, increased heme-derived iron absorption may exacerbate tissue iron deposition. Targeting heme transporters might provide new strategies to manage iron-related metabolic disorders.
Heme Transport in Cancer and Neurodegeneration
Altered heme transport is observed in cancer cells, which often have increased iron demands for proliferation. SLCO2B1 upregulation may support tumor growth by enhancing iron availability. In neurodegeneration, impaired heme transport can lead to oxidative stress and neuronal damage, as seen in FLVCR1-related neuropathy. These connections underscore the broad impact of heme transport on human health.
From heme transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X transport heme? | Knockout cell line with heme uptake assay |
| What is the effect of a point mutation in transporter Y? | Point mutation knock-in via CRISPR |
| Where is the transporter localized? | Tagged knock-in with fluorescent protein |
| Does overexpression of transporter Z increase iron availability? | Overexpression stable cell line |
| Which genes regulate heme transport? | CRISPR library screening |
| How does heme transport affect erythropoiesis? | Erythroid differentiation of knockout iPSCs |
How to Study the heme transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR activation screen | Genes that enhance heme uptake | Discovery of novel transporters |
| Radiolabeled heme uptake assay | Rate of heme transport | Kinetic characterization of transporters |
| Fluorescent heme imaging | Intracellular heme distribution | Localization studies |
| Proteomics | Heme-protein interactions | Identifying transport complexes |
| RNA-seq | Gene expression changes | Regulatory network analysis |
| ChIP-seq | Transcription factor binding | Identifying regulators of transport genes |
| Mitochondrial heme export assay | Heme efflux from mitochondria | Studying mitochondrial transporters |
| Iron availability assay | Cellular iron levels | Functional impact of heme transport |
Genetic Screens for Heme Transporters
Metabolic-scale gene activation screens have been used to identify SLCO2B1 as a heme transporter that enhances cellular iron availability. Such screens combine CRISPR activation libraries with phenotypic readouts of iron status or heme uptake, enabling unbiased discovery of transport genes. These approaches can be adapted to other cell types and conditions to uncover context-specific transporters.
Biochemical Assays for Heme Transport
Direct measurement of heme transport can be achieved using radiolabeled heme or fluorescent heme analogs in uptake and efflux assays. These assays are often performed in cells overexpressing or lacking candidate transporters to determine specificity and kinetics. Mitochondrial heme transport can be studied using isolated mitochondria and heme-sensitive probes.
Imaging and Proteomics
Fluorescence imaging with heme-binding proteins or genetically encoded heme sensors allows visualization of heme distribution in live cells. Proteomic approaches can identify heme-binding proteins and interaction partners of transporters, providing mechanistic insights. Combining imaging with organelle markers reveals the intracellular routes of heme trafficking.
Transcriptomic and Regulatory Analysis
RNA-seq and ChIP-seq can reveal transcriptional regulation of heme transport genes under different conditions, such as iron deficiency or hypoxia. Integrating these data with metabolic profiles helps build regulatory networks linking heme transport to cellular metabolism.
How CRISPR Can Be Used to Study GO:0015886 heme transport
Knockout
CRISPR knockout of candidate heme transport genes, such as SLCO2B1 or ABCB10, allows researchers to assess their necessity for heme uptake, distribution, and cellular iron homeostasis. Knockout cell lines can be subjected to heme transport assays and phenotypic analyses to confirm gene function.
Point Mutation
Introducing disease-associated point mutations into heme transport genes via CRISPR base editing or homology-directed repair enables the study of altered transporter activity and its consequences for heme metabolism. Such models are valuable for understanding genetic variants linked to anemias or porphyrias.
Knock-in
Tagged knock-in of heme transporters with fluorescent or affinity tags facilitates real-time tracking of protein localization and interaction partners. This approach can reveal dynamic trafficking of transporters between cellular compartments.
Overexpression
CRISPR activation or cDNA overexpression of heme transporters like SLCO2B1 can enhance heme uptake and iron availability, providing gain-of-function models to study transport capacity and downstream metabolic effects. Overexpression models are useful for screening inhibitors or activators of heme transport.
How EDITGENE Supports heme transport Research
Researchers studying heme transport-related genes often need to determine whether a candidate gene is causally involved in heme movement, iron homeostasis, or disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of heme transport genes.
Contact EDITGENE today to design your custom CRISPR model for heme transport research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| HPX Knockout HEK293 Cell Line | EDJ-KQ3150 | Human | 3263 | Details Get a Quote |
| ABCB6 Knockout HEK293 Cell Line | EDJ-KQ6880 | Human | 10058 | Details Get a Quote |
| PGRMC2 Knockout HEK293 Cell Line | EDJ-KQ7042 | Human | 10424 | Details Get a Quote |
| SLC46A1 Knockout HEK293 Cell Line | EDJ-KQ7415 | Human | 113235 | Details Get a Quote |
| FLVCR1 Knockout HEK293 Cell Line | EDJ-KQ8951 | Human | 28982 | Details Get a Quote |
| SLC48A1 Knockout HEK293 Cell Line | EDJ-KQ12229 | Human | 55652 | Details Get a Quote |
| FLVCR1 Knockout HeLa Cell Line | EDJ-KQ34092 | Human | 28982 | Details Get a Quote |
| SLC48A1 Knockout A-549 Cell Line | EDJ-KQ40990 | Human | 55652 | Details Get a Quote |
| SLC48A1 Knockout HCT 116 Cell Line | EDJ-KQ40991 | Human | 55652 | Details Get a Quote |
| SLC48A1 Knockout HeLa Cell Line | EDJ-KQ40992 | Human | 55652 | Details Get a Quote |
| HPX Knockout HCT 116 Cell Line | EDJ-KQ24549 | Human | 3263 | Details Get a Quote |
| SLC46A1 Knockout A-549 Cell Line | EDJ-KQ31225 | Human | 113235 | Details Get a Quote |
| ABCB6 Knockout A-549 Cell Line | EDJ-KQ31473 | Human | 10058 | Details Get a Quote |
| ABCB6 Knockout HCT 116 Cell Line | EDJ-KQ31474 | Human | 10058 | Details Get a Quote |
| ABCB6 Knockout HeLa Cell Line | EDJ-KQ31475 | Human | 10058 | Details Get a Quote |
Displaying Records 1 To 15 Of 24 Records
Frequently Asked Questions About heme transport
What is heme transport (GO:0015886)?
Heme transport is the directed movement of heme, an iron-porphyrin complex, into, out of, or within a cell, or between cells, by means of transporters or pores.
What genes are involved in heme transport?
Key genes include SLCO2B1, ABCB10, FLVCR1, HRG1, HEPH, HPX, and others that encode transporters or heme-binding proteins.
Why is heme transport important for erythropoiesis?
Erythropoiesis requires large amounts of heme for hemoglobin; transport ensures heme availability and iron recycling in red blood cell precursors.
How is heme transported into mitochondria?
Mitochondrial heme transport involves specific export and import machinery, including ABCB10, to move heme across membranes for synthesis and respiratory chain assembly.
What diseases are linked to defective heme transport?
Defects in heme transport are associated with anemias, porphyrias, iron overload, and neurodegenerative conditions like FLVCR1-related neuropathy.
What is the role of SLCO2B1 in heme transport?
SLCO2B1 is a heme transporter that enhances cellular iron availability, identified through metabolic-scale gene activation screens.
How can I study heme transport using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of heme transport genes in relevant cell types.
What methods measure heme transport?
Radiolabeled heme uptake assays, fluorescent heme imaging, proteomics, and genetic screens are commonly used to measure and study heme transport.
Is heme transport regulated by iron levels?
Yes, iron regulatory proteins and transcription factors like HIF1A modulate the expression of heme transport genes in response to iron status.
What is the hemopexin heme transport system?
The hemopexin system binds free heme in plasma and delivers it to cells via receptors like CD91, protecting against oxidative damage and recycling iron.
Conclusion
Heme transport (GO:0015886) is a fundamental biological process that ensures the proper distribution of heme for essential cellular functions, including oxygen transport, respiration, and iron homeostasis. Its dysregulation contributes to a range of diseases, from anemias to metabolic disorders, making it a critical area of research. Advances in CRISPR-based models and screening technologies are accelerating the discovery of new transporters and regulatory mechanisms, offering hope for targeted therapies.
References
- 1. Ali SF et al.. 2025. Mechanisms of heme transport in the mitochondria.. Biochem Soc Trans 53(3):603-614 PMID: 40440032
- 2. Yuan X et al.. 2013. Heme transport and erythropoiesis.. Curr Opin Chem Biol 17(2):204-11 PMID: 23415705
- 3. Belot A et al.. 2024. Update on heme biosynthesis, tissue-specific regulation, heme transport, relation to iron metabolism and cellular energy.. Liver Int 44(9):2235-2250 PMID: 38888238
- 4. Andrews NC. 2005. Understanding heme transport.. N Engl J Med 353(23):2508-9 PMID: 16339100
- 5. Unlu G et al.. 2022. Metabolic-scale gene activation screens identify SLCO2B1 as a heme transporter that enhances cellular iron availability.. Mol Cell 82(15):2832-2843.e7 PMID: 35714613
- 6. Cao C et al.. 2015. The ins and outs of erythroid heme transport.. Haematologica 100(6):703 PMID: 26034110
- 7. Ri K et al.. 2024. Molecular mechanism of choline and ethanolamine transport in humans.. Nature 630(8016):501-508 PMID: 38778100
- 8. Smith A. 2000. Links between cell-surface events involving redox-active copper and gene regulation in the hemopexin heme transport system.. Antioxid Redox Signal 2(2):157-75 PMID: 11229523
